SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
AIDS MALIGNANCIES AND KSHV
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
HPV VACCINE WITH LEEP DID NOT PREVENT RECURRENT CERVICAL HSIL IN HIV-INFECTED WOMEN (ABSTRACT
14)
Cindy Firnhaber
University of Colorado Medical Center, Aurora, CO, USA
OPTIMAL LUNG CANCER SCREENING CRITERIA AMONG PERSONS LIVING WITH HIV (ABSTRACT
15)
Subhashini A Sellers
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
HIV IS ASSOCIATED WITH DECREASED BREAST CANCER SURVIVAL: A PROSPECTIVE COHORT STUDY (ABSTRACT
16)
Katrin Sara Sadigh
Brigham and Women's Hospital, Boston, MA, USA
LONG-TERM OUTCOMES OF 58 PATIENTS WITH HIV AND KSHV+ MULTICENTRIC CASTLEMAN DISEASE (ABSTRACT
17)
Ramya Ramaswami
HIV AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
REDUCTION OF KAPOSI SARCOMA–ASSOCIATED HERPESVIRUS LATENCY USING CRISPR-CAS9 (ABSTRACT
18)
For Yue Tso
University of Nebraska - Lincoln, Lincoln, NE, USA
THE ROLE OF WILMS' TUMOR 1 IN KAPOSI SARCOMA HERPESVIRUS ONCOGENESIS (ABSTRACT
19)
Ayana Morales
Weill Cornell Medical College, New York, NY, USA
QUANTIFICATION OF KSHV DNA AS A DIAGNOSTIC TEST FOR KAPOSI SARCOMA IN AFRICA (ABSTRACT
20)
Aggrey Semeere
Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
TWO NOVEL POTENTIAL THERAPEUTIC TARGETS IN THE KSHV LIFE CYCLE (ABSTRACT
21)
Thomas Schulz
Medizinischen Hochschule Hannover, Hannover, Germany
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
